Ultrasound Contrast Agents Market

Ultrasound Contrast Agents Market Segmentation by Therapeutic Area (Cardiovascular Diseases, Renal Associated Diseases, and Others); by Application (Molecular Imaging, Gene Therapy, Drug Delivery, and Stem Cell Delivery); and by End-User (Hospital, Diagnostic Centres, Ambulatory Surgical Centres, and Others) – Global Demand Analysis and Opportunity Outlook 2030

Buy Now
Report ID: 3241 | Published On: Apr 04, 2022

Preview Analysis

Request Insights
Despite Inflation & Recession News, Businesses Across the Globe Expected to Do Better in 2023

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

In The News

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Ultrasound Contrast Agents Market Regional Synopsis

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific is predicted to grow at the highest CAGR over the forecast period owing to the increasing necessity for advanced diagnosis methods to detect various disease indications such as neurological disorders, cancer, cardiovascular diseases, and others. Moreover, the developing healthcare sector, supported by the increasing government investment in the public healthcare system is also expected to boost the market growth.

The market in the North America is evaluated to occupy the largest share in terms of revenue, by the end of 2030, owing to the increasing prevalence of cardiovascular diseases in the region. According to American Heart Association, in 2017, CVD has been listed as one of the most prominent underlying causes of death in the United States, which accounted for around 74% of all deaths. As per the data by the CDC, one person dies every 36 seconds in the United States from cardiovascular diseases. Such an increasing number of CVD cases in the United States has significantly increased the demand for ultrasound examination in this region, which is further expected to drive the demand for ultrasound contrast agents in the region.


Get more information on this reportDownload Sample PDF

The global ultrasound contrast agents market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global ultrasound contrast agents market includes the following segments:

By Therapeutic Area

  • Cardiovascular Diseases
  • Renal Associated Diseases
  • Others

By Application

  • Molecular Imaging
  • Gene Therapy
  • Drug Delivery
  • Stem Cell Delivery

By End-user

  • Hospital
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Others

Growth Drivers

  • Growing Use of Ultrasound Diagnosis
  • Increasing Prevalence of Chronic Diseases Globally


  • Allergic Reactions and Side Effects
  • Short Term Effect of the Agents

Get more information on this report: Request Sample PDF

Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

    • Bristol-Myers Squibb
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • GE Healthcare
    • Lantheus Holdings, Inc.
    • Bracco Diagnostic Inc.
    • Merck & Company, Inc.
    • AstraZeneca Plc.
    • Siemens Healthcare GmbH
    • Mindray Medical International Limited
    • Daiichi Sankyo Company
    • Nano Therapeutics Pvt Ltd


Key Questions Answered in the Report

1) What are the major factors driving the growth of the ultrasound contrast agents market?

Ans: Rising prevalence of chronic disorders and increasing implementation of ultrasound diagnosis are the key factors driving market growth.

2) What would be the CAGR of ultrasound contrast agents market over the forecast period?

Ans: The market is anticipated to attain a ~20% CAGR over the forecast period, i.e., 2022-2030.

3) What are the challenges affecting the ultrasound contrast agents market growth?

Ans: Allergic reactions & side effects and short-term effect of the ultrasound contrast agents are estimated to hamper market growth.

4) Which region will provide more business opportunities for growth of ultrasound contrast agents market in future?

Ans: The market in North America region will provide ample growth opportunities over the forecast period owing to the increasing number cardiovascular diseases in the region.

5) Who are the major players dominating the ultrasound contrast agents market?

Ans: The major players dominating the ultrasound contrast agents market are Bristol-Myers Squibb, GE Healthcare, Lantheus Holdings, Inc., Bracco Diagnostic Inc., Siemens Healthcare GmbH, and others.

6) How are the company profiles selected?

Ans: The company profiles are selected on the basis of revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the ultrasound contrast agents market?

Ans: The market is segmented by therapeutic area, application, end-user, and region.

8) Which segment under the therapeutic area segment captures the largest market size in the ultrasound contrast agents market?

Ans: With respect to therapeutic area, the cardiovascular segment is anticipated to hold the largest market share owing to the increasing incidence of cardiovascular diseases globally.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Submit RFP    Buy Now Download Research Report Sample